AI in Detecting Sleep Disorders Market Size to Reach USD 983.26 Million by 2033 as Wearables, Sleep Apnea Detection, and AI-Led Home Monitoring Expand Clinical Use

April 19, 2026 - The global AI in Detecting Sleep Disorders Market reached USD 486.22 million in 2024 and is expected to reach USD 983.26 million by 2033, growing at a CAGR of 8.2% during 2025-2033, based on the market data provided. The market is advancing as AI shifts sleep monitoring from lab-heavy testing toward more continuous, consumer-friendly, and home-based assessment across wearables, connected sensors, and software-led sleep analysis. DataM Intelligence describes the market as being driven by machine learning, deep learning, and data analytics applied to sleep-related data from wearables, sensors, and medical devices.

Request Updated Sample: https://www.datamintelligence.com/download-sample/ai-in-detecting-sleep-disorders-market?kailas

Demand is rising across wearable and non-wearable devices, sensing, computing, and display technologies, and applications such as obstructive sleep apnea, insomnia, narcolepsy, and restless leg syndrome. The surrounding sleep-tech ecosystem also supports this trend: the global wearable sleep trackers market was estimated at USD 13.4 billion in 2023 by Grand View Research, while the broader sleep tech devices market is currently segmented directly into wearables and non-wearables, mirroring the structure of your supplied market.

Recent Developments

Recent developments show that the market is moving toward broader consumer screening, digital insomnia care, and commercial scaling of AI-led sleep platforms. In September 2025, Apple launched Apple Watch Series 11 and added new sleep-quality insights, building on the company's earlier rollout of sleep-health features. Apple's support materials also say the Sleep Apnea Notifications Feature can look for breathing disturbances during sleep and notify users when patterns show consistent signs of moderate to severe sleep apnea.

In February 2026, Big Health announced USD 23.7 million in new funding to accelerate adoption of its FDA-cleared digital mental health products, including SleepioRx for insomnia disorder. The company says SleepioRx is an FDA-cleared digital treatment delivering CBT-I through a mobile app.

Sleep Cycle's official investor site says the company reported SEK 248 million in 2025 net sales and positions itself as an AI-powered sleep analysis company. Its investor materials also highlight long-term expansion into medtech and sleep apnea risk detection, showing how sleep analytics platforms are moving closer to clinical use cases.

Segment Analysis
By Device Type: Wearable Devices

Wearable devices appear to be the leading segment because AI-enabled sleep detection is increasingly tied to consumer devices that can capture sleep patterns continuously at home. The broader wearable sleep trackers market reached USD 13.41 billion in 2023, showing that device familiarity, ecosystem scale, and user adoption are already well established. Based on that surrounding market structure, wearables are likely the strongest commercial segment inside AI-based sleep-disorder detection, especially for screening and early monitoring. I am treating this as a directional segment lead because I did not find an open public source with an exact share split for this niche market.

By Application: Obstructive Sleep Apnea

Obstructive sleep apnea is the clearest leading application segment. Grand View Research estimates the global sleep apnea devices market at USD 4.5 billion in 2023, while IMARC says the market reached USD 9.0 billion in 2025 and that North America held 49.2% share that year. These adjacent-market figures strongly indicate that OSA remains the most commercially significant clinical use case for AI-based sleep detection, especially where wearables and algorithmic screening can reduce reliance on traditional lab pathways.

Market Segmentation

The AI in Detecting Sleep Disorders Market is segmented by Device Type into Wearable Devices and Non-Wearable Devices. By Technology, it includes Sensing Technology, Computing Technology, and Display Technology. By Application, the market covers Obstructive Sleep Apnea, Insomnia, Narcolepsy, Restless Leg Syndrome, and Others. By End-User, it includes Hospitals, Homecare Settings, Neurological Centers, Research Institutions, and Others. Regionally, the market spans North America, Latin America, Europe, and Asia Pacific. The companies cited in the market include Fullpower Technologies, Apple Inc., Endel, Big Health, dbbeats, Dr.BreathE, Neybox Digital Ltd., SleepUp Limited, Calm.com, and Sleep Cycle AB, among others.

Regional Analysis
United States

The United States remains the most important national market because of its large sleep-apnea patient base, high wearable adoption, strong digital-health spending, and early commercialization of AI-enabled sleep tools. IMARC estimates the U.S. sleep apnea devices market at USD 2,210.8 million in 2025, while Grand View Research projects the U.S. market to reach USD 2,238.8 million by 2030. Using the IMARC figure as a directional benchmark against your global AI-in-detecting-sleep-disorders market size of USD 486.22 million in 2024 is not apples-to-apples, but it clearly shows the U.S. is the largest national opportunity in the broader sleep-diagnostics ecosystem.

Growth trends in the U.S. are being driven by home screening, consumer wearables, and digital insomnia treatment. Apple's sleep-apnea notification rollout and Big Health's FDA-cleared SleepioRx both reinforce the shift toward AI-supported, home-based, software-heavy sleep management in the U.S. market.

Japan

Japan is an important Asia-Pacific market because of its aging population, growing sleep-health awareness, and strong demand for compact, home-oriented monitoring technologies. IMARC estimates the Japan sleep apnea devices market at USD 526 million in 2024 and USD 561.8 million in 2025, while Grand View Research separately estimated USD 162.7 million in 2023 for Japan with an 8.1% CAGR to 2030. These figures come from adjacent sleep-apnea-device categories rather than this exact AI niche, so they are best treated as directional indicators rather than direct equivalents.

Japan's growth profile is supported by rising device adoption and a broader consumer openness to digital wellness tools. That makes it one of the more promising regional markets for AI-enabled sleep detection, especially across homecare and wearable formats.

Purchase This Exclusive Report: https://www.datamintelligence.com/buy-now-page?report=ai-in-detecting-sleep-disorders-market?kailas

Company Profiles
Apple Inc.

Apple is one of the most influential companies in this market because it has brought sleep tracking and sleep apnea screening into a mass-market wearable platform. Apple's September 2025 launch of Apple Watch Series 11 added new sleep-quality insights, and the company's support documentation says its sleep apnea notification feature can identify signs of moderate to severe sleep apnea from breathing disturbances during sleep. That gives Apple one of the strongest consumer-scale positions in AI-enabled sleep detection.

Big Health

Big Health is highly relevant in the insomnia-focused side of the market. The company announced USD 23.7 million in funding in February 2026 and says its flagship product SleepioRx is an FDA-cleared digital treatment for chronic insomnia or insomnia disorder. Big Health's official materials position SleepioRx around clinically guided CBT-I delivered in app form, making it a strong software-led player in AI-adjacent sleep disorder management.

Sleep Cycle AB

Sleep Cycle is one of the clearest AI-native players in consumer sleep analysis. Its investor site says the company reported SEK 248 million in 2025 net sales, has 30+ employees, and positions itself as a world leader in AI-powered sleep analysis. Sleep Cycle also states that its SDK allows third parties to embed its proprietary AI sound model into their own apps, devices, or services, which strengthens its relevance in scalable sleep-tech deployments.

Analyst View

The market is moving from basic sleep tracking toward clinically meaningful AI-led detection, especially in wearables and obstructive sleep apnea use cases. The United States remains the clearest scale market because of digital-health commercialization and consumer device adoption, while Japan offers strong long-term potential through home-monitoring and sleep-device demand. Companies that can combine validated algorithms, easy-to-use hardware, and practical home-based workflows are likely to capture the largest share of growth as the market advances toward USD 983.26 million by 2033.

Contact:
Fabian
DataM Intelligence 4market Research LLP
6th Floor, M2 Tech Hub, DataM Intelligence 4market Research LLP, Lalitha Nagar, Habsiguda, Secunderabad, Hyderabad, Telangana 500039
USA: +1 877-441-4866
UK: +44 161-870-5507
Email: fabian@datamintelligence.com

About DataM Intelligence
DataM Intelligence is a renowned provider of market research, delivering deep insights through pricing analysis, market share breakdowns, and competitive intelligence. The company specializes in strategic reports that guide businesses in high-growth sectors such as nutraceuticals and AI-driven health innovations.
To find out more, visit https://www.datamintelligence.com/ or follow us on Twitter, LinkedIn and Facebook.

This release was published on openPR.